BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Le Berre C, Ricciuto A, Peyrin-Biroulet L, Turner D. Evolving Short- and Long-Term Goals of Management of Inflammatory Bowel Diseases: Getting It Right, Making It Last. Gastroenterology 2022;162:1424-38. [PMID: 34995529 DOI: 10.1053/j.gastro.2021.09.076] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Lee WS, Arai K, Alex G, Treepongkaruna S, Kim KM, Choong CL, Mercado KC, Darma A, Srivastava A, Aw MM; APPSPGHAN PIBD Working Group. Management and monitoring of pediatric inflammatory bowel disease in the Asia-Pacific region: A position paper by the Asian Pan-Pacific Society for Pediatric Gastroenterology, Hepatology, and Nutrition (APPSPGHAN) PIBD Working Group: Surgical management, disease monitoring, and special considerations. J Gastroenterol Hepatol 2022. [PMID: 36508314 DOI: 10.1111/jgh.16084] [Reference Citation Analysis]
2 Dai YC, Qiao D, Fang CY, Chen QQ, Que RY, Xiao TG, Zheng L, Wang LJ, Zhang YL. Single-cell RNA-sequencing combined with bulk RNA-sequencing analysis of peripheral blood reveals the characteristics and key immune cell genes of ulcerative colitis . World J Clin Cases 2022; 10(33): 12116-12135 [DOI: 10.12998/wjcc.v10.i33.12116] [Reference Citation Analysis]
3 Chen B, Wang Y, Wang Q, Li D, Huang X, Kuang X, Wang S, Hu Z. Untargeted metabolomics identifies potential serum biomarkers associated with Crohn’s disease. Clin Exp Med 2022. [DOI: 10.1007/s10238-022-00931-z] [Reference Citation Analysis]
4 Peyrin-Biroulet L, Ghosh S, Lee SD, Lee WJ, Griffith J, Wallace K, Berg S, Liao X, Panes J, Loftus EV Jr, Louis E. Effect of risankizumab on health-related quality of life in patients with Crohn's disease: results from phase 3 MOTIVATE, ADVANCE and FORTIFY clinical trials. Aliment Pharmacol Ther 2022. [PMID: 36266762 DOI: 10.1111/apt.17242] [Reference Citation Analysis]
5 Nardone OM, Cannatelli R, Ghosh S, Iacucci M. New endoscopic tools in inflammatory bowel disease. United European Gastroenterol J 2022;10:1103-12. [PMID: 36225117 DOI: 10.1002/ueg2.12316] [Reference Citation Analysis]
6 Nardone OM, Ponsiglione A, de Sire R, Calabrese G, Liuzzi R, Testa A, Guarino AD, Olmo O, Rispo A, Camera L, Castiglione F. Impact of Sarcopenia on Clinical Outcomes in a Cohort of Caucasian Active Crohn’s Disease Patients Undergoing Multidetector CT-Enterography. Nutrients 2022;14:3460. [DOI: 10.3390/nu14173460] [Reference Citation Analysis]
7 Li M, Wang F, Zhang C, Li MA, Wang T, Li YC, Fu FH. Integrated systematic pharmacology analysis and experimental validation to reveal the mechanism of action of Semen aesculi on inflammatory bowel diseases. J Ethnopharmacol 2022;298:115627. [PMID: 35985613 DOI: 10.1016/j.jep.2022.115627] [Reference Citation Analysis]
8 Hart AL, Rubin DT. Entering the Era of Disease Modification in Inflammatory Bowel Disease. Gastroenterology 2022;162:1367-9. [PMID: 35202593 DOI: 10.1053/j.gastro.2022.02.013] [Reference Citation Analysis]